Setback for Sativex

Last week, UK-based GW Pharmaceuticals acknowledged that its cannabis-based oral spray, Sativex, failed a late-stage clinical trial as the experimental drug showed no evidence of reducing pain in cancer patients.

Participants in the initial Phase 3 trial were given Sativex, which is sprayed in the mouth, or a placebo three to 10 times a day for five weeks. However, test subjects receiving Sativex reported a statistically insignificant difference in pain relief from those receiving the placebo.

The disappointing trial results initially plunged GW stock around 13 percent on the morning of January 8, the first poor showing from the company since it listed on Nasdaq in 2013. But thanks to an encouraging update on GW’s cannabis-based childhood epilepsy drug Epidiolex, the company’s stock actually rebounded and closed up two percent.

The Phase 3 results are viewed by some as a blow against cannabis-based pharmaceutical products, as opposed to the entire plant in its pure, natural and medically effective form.

GW is scheduled to conduct further Phase 3 trials later this year and the company is hopeful that Sativex will eventually be approved for pain treatment in cancer patients. “Although we missed the primary endpoint in this trial, based upon the positive data seen in the Phase 2 program, we remain confident in the ability for Sativex to relieve cancer pain in this patient population,” GW chief executive Justin Gover said.

Sativex is currently approved for treating symptoms of multiple sclerosis.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts
Spain
Read More

Jon’s Stone-Cold Cop List #48: Americans in Spain

For March’s Cop List our VP of Content includes a collection of products from both America and Spain. This month’s list includes Hall of Flame, Heirbloom, Bando Farmers, No Till Kings, the Bud Professor and more…
Rick Ross
Read More

Recreational Rapper Weed: The Rick Ross Interview

High Times caught up with millionaire mogul and rapper Rick Ross to talk about weed, rapping, and his recent entry into the recreational cannabis market with Los Angeles-based High Tolerance.
Güd Gardens
Read More

Going Rogue

Güd Gardens offers an expansive selection of unique cultivars.
Bruno
Read More

Bruno Worldwide

The West Coast’s favorite bowtied roller hits Europe.
Hashem
Read More

Comedian Dina Hashem Senses a Gulf

The Comedy Cellar and Gotham Comedy Club regular, who also wrote for The Sex Lives of College Girls, recently spoke to High Times about her style, despising the Sheraton Hotel, and enjoying psychedelics.
Total
0
Share